ATE107705T1 - Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten. - Google Patents

Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten.

Info

Publication number
ATE107705T1
ATE107705T1 AT87100550T AT87100550T ATE107705T1 AT E107705 T1 ATE107705 T1 AT E107705T1 AT 87100550 T AT87100550 T AT 87100550T AT 87100550 T AT87100550 T AT 87100550T AT E107705 T1 ATE107705 T1 AT E107705T1
Authority
AT
Austria
Prior art keywords
associated diseases
dna
test
susceptibility
determine susceptibility
Prior art date
Application number
AT87100550T
Other languages
English (en)
Inventor
Ronald W Pero
Daniel G Miller
Original Assignee
Ronald W Pero
Daniel G Miller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ronald W Pero, Daniel G Miller filed Critical Ronald W Pero
Application granted granted Critical
Publication of ATE107705T1 publication Critical patent/ATE107705T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87100550T 1986-01-17 1987-01-16 Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten. ATE107705T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82020386A 1986-01-17 1986-01-17

Publications (1)

Publication Number Publication Date
ATE107705T1 true ATE107705T1 (de) 1994-07-15

Family

ID=25230175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100550T ATE107705T1 (de) 1986-01-17 1987-01-16 Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten.

Country Status (6)

Country Link
US (1) US5482833A (de)
EP (1) EP0229674B1 (de)
JP (1) JP2534631B2 (de)
AT (1) ATE107705T1 (de)
DE (1) DE3750093T2 (de)
ES (1) ES2056790T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449605A (en) * 1988-10-14 1995-09-12 Georgetown University Method of detecting a predisposition to cancer by detecting a deletion polymorphism in the gene for human poly (ADP-ribose) polymerase
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
DE69533200T2 (de) * 1994-10-27 2005-09-29 Optigenex, Inc. Verfahren zur prüfung von immunokompetenz
FR2731711B1 (fr) * 1995-03-15 1997-06-06 Rech Investissements Sfri Soc Procede de detection qualitative et quantitative de lesions de l'adn
US6017706A (en) * 1997-05-07 2000-01-25 The United States Of America As Represented By The Department Of Health And Human Services Process for identifying compounds which protect against the formation of fluorescent light induced DNA lesions and x-ray-induced lesions
US6640211B1 (en) * 1999-10-22 2003-10-28 First Genetic Trust Inc. Genetic profiling and banking system and method
CA2441436C (en) * 2001-03-23 2011-06-07 Yeda Research And Development Co., Ltd. Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer
US20030003454A1 (en) * 2001-03-23 2003-01-02 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
WO2005123955A2 (en) * 2004-06-09 2005-12-29 Children's Medical Center Corporation Methods and compositions for modifying gene regulation and dna damage in ageing
AU2006257815A1 (en) * 2005-06-10 2006-12-21 Bipar Sciences, Inc. PARP modulators and treatment of cancer
NZ565654A (en) * 2005-07-18 2010-10-29 Bipar Sciences Inc Use of iodonitrobenzamide compounds for the treatment of ovarian cancer
US8381164B2 (en) * 2006-03-28 2013-02-19 The Boeing Company Method and system of intelligent interactive graphics electrical plug map to analyze text and distances between electrical contacts and physical layout file builder
US20100279327A1 (en) * 2006-06-12 2010-11-04 Bipar Sciences, Inc. Method of treating diseases with parp inhibitors
CA2655257A1 (en) * 2006-06-12 2008-12-04 Bipar Sciences, Inc. Method of treating diseases with parp inhibitors
CA2662337A1 (en) * 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
WO2008030883A2 (en) * 2006-09-05 2008-03-13 Bipar Sciences, Inc. Treatment of cancer
JP2011503111A (ja) * 2007-11-12 2011-01-27 バイパー サイエンシズ，インコーポレイティド Ｐａｒｐ阻害剤単独又は抗腫瘍剤との組み合わせによる乳がんの治療
CA2705417A1 (en) * 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents
AU2008333786A1 (en) * 2007-12-07 2009-06-11 Bipar Sciences, Inc. Treatment of cancer with combinations of topoisomerase inhibitors and PARP inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585736A (en) * 1983-10-18 1986-04-29 The United States Of America As Represented By The United States Department Of Energy Flow cytometric measurement of total DNA and incorporated halodeoxyuridine

Also Published As

Publication number Publication date
EP0229674A3 (en) 1989-08-16
ES2056790T3 (es) 1994-10-16
EP0229674A2 (de) 1987-07-22
US5482833A (en) 1996-01-09
DE3750093D1 (de) 1994-07-28
EP0229674B1 (de) 1994-06-22
JPS62224300A (ja) 1987-10-02
JP2534631B2 (ja) 1996-09-18
DE3750093T2 (de) 1995-01-26

Similar Documents

Publication Publication Date Title
ATE107705T1 (de) Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten.
DE3751195D1 (de) Indikator für Systemaktivitätsänderungen.
DE3578190D1 (de) Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen.
DE3583716D1 (de) Diagnostische testmethoden.
EP0133671A3 (en) Detection of bacteria by nucleic acid hybridization, labeled probes and test kit therefore
DE3579099D1 (de) Dna-sonden mit verbindungsfragment und sondengruppe.
FI864964A7 (fi) Nukleiinihappojaksojen määrittämiseen soveltuvia molekyylejä.
FI873495L (fi) Foerstaerkt hybridiseringsanalys.
FI910396A7 (fi) Veteen liukenematon reagenssi, nukleiinihappokoetin, testipakkaus sekä diagnostisia ja puhdistusmenetelmiä
ES8609472A1 (es) Una sonda de deteccion de acidos nucleicos
IS3350A7 (is) Efnabætt næringarefni og aðferð til framleiðslu þess ( efnabætt með nucleosides og/eða nucleotides)
IT8720645A0 (it) Strumento di misura per bio e chemioluminescenza o per misure di estinzione.
FI883868A7 (fi) Anturi biologista, biokemiallista ja kemiallista koestusta varten
EP0200057A3 (en) Diagnostic reagent, kit and method employing polynucleotide displacement, separation, enzymatic cleavage and adenosine phosphate detection
ZA853756B (en) Nucleic acid hybridization assay employing immobilized rna probes
EP0182225A3 (en) Enzymatic high range glucose test
IL71715A0 (en) Method,gene probes and test kit for detecting bacteria by nucleic acid hybridization
ATE92523T1 (de) Verfahren zur abtrennung und reinigung von sialyl-transferasen.
DE3583693D1 (de) Vorrichtung zur messung der geschwindigkeit einer enzymatischen reaktion.
DK371584A (da) N6-substituerede adenosiner, fremgangsmaade til deres fremstilling samt deres anvendelse
DE3578454D1 (de) Klinisches analysesystem und verfahren.
DE3669043D1 (de) Testreagenzien.
DE3788360D1 (de) Signalverarbeitung für Berührungstastkopf.
EP0304215A3 (de) Phosphorylierungsreagenz und Verfahren zu seiner Verwendung
FI882800A7 (fi) Parannettu nukleiinihappohybridisaatiotekniikka ja testipakkaus.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee